NCT04328766

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

An Open-Label, Multiple-Dose Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

An open-label, multiple-dose clinical trial to evaluate the safety/tolerability and pharmacokinetic interaction between DWP14012 and DWC202005 in healthy volunteers

Conditions

• Drug-drug Interaction

Interventions

Type	Name	Description
DRUG	DWC202005, alone	DWC202005, as a single dose
DRUG	DWP14012 + DWC202005	DWP14012 and DWC202005, as a single dose
DRUG	DWP14012 + DWC202005, after multiple doses of DWP14012	DWP14012 and DWC202005, after multiple oral doses of DWP14012 once daily for 12 days

Timeline

• Start date: 2020-09-06
• Primary completion: 2020-11-21
• Completion: 2020-11-21
• First posted: 2020-03-31
• Last updated: 2021-08-16

Locations

1 site across 1 country: Australia